UniCredit Bank AG (UR9ZQD) Quote

https://t.me/Next10x

Join this group, it’s not really that active but handy to get in touch with some people. We can talk stocks.

Wrong again

Dar53...Amarin is a company, which depends on a volume of sales from its ONE product...Generics are companies, which depend on volumes of sales from their MANY products...When generic companies assess their balance sheets, they tolerate a small volume and a small margin from any ONE of their MANY pr

MLGO one more round $4.60 + 30%

AbbVie price target raised to $190 from $185 at Piper Sandler
Piper Sandler raised the firm's price target on AbbVie to $190 from $185 and keeps an Overweight rating on the shares. The firm highlights two new U.S. gastroenterologist surveys that would seem to support management's commentary t

OK 🙄 You are entitled to your own opinion however you are not entitled to your own facts. The CEO's wife purchased $4002.00 worth of stock at the low of the day on June 5th. That was 10,005,000 shares at $0.0004. Then on June 6th 26,425,000 shares priced at $0.0004 for another $10,570. Relat

NOPAIN Act
Jan. 1, 2025

https://www.congress.gov/bill/117th-congress/house-bill/3259/text?s=2&r=1&q=%7B%22search%22%3A%22NOPAIN+ACT%22%7D

Just to highlight a few points::

(G) ACCESS TO NON-OPIOID TREATMENTS FOR PAIN.—
“(i) IN GENERAL.—

TBLT 3.65 + 19% CHGG $3.12 +19% up on firing 1/5th of its employees GWAV 2.07 + 11% KTRA .2080 + 16%

This is exactly what happened to me - two years after the BBX...

The hospital prescribed it improperly and when I wanted to quit the doctor failed and said I couldn't quit...

2/25/18.... the date is irrevocably etched in my brain.


In 2016, the U

Are they closing up?

I think last week's new shelf offering indicates they don't have the 1.4 on hand. Curious to see how it will be used.

And yeah the equity conditions clause seems like either a deliberate head fake or a gross miscalculation.

The only thing that could conceivably forgive

Nvidia price target raised to $200 from $140 at Rosenblatt

I highly recommend using some logic when trying to make a point. Not only does it help the reader understand what you’re saying it also helps in bringing about good discussion.

Try it sometime!

You have telegram? We could alert eachother about those movers. See PWDY too. The whole OTC is in a much better state than it was last couple of years. PPCB back to +$0.002? Hope the ones converting here know what they doing and let it breath near that 200MA.

PSQ Holdings Announces Intent to Migrate PublicSquare Marketplace to Rumble Cloud Platform

https://stockhouse.com/news/press-releases/2024/06/17/psq-holdings-announces-intent-to-migrate-publicsquare-marketplace-to-rumble

Goooood BEAUTIFUL $RNVA morning!!!

Ouch! HAHAHAHAHAHAHAHA!!!! Waiting to see how this ends…….

Pluri Subsidiary Ever After Foods Secured $10 Million Strategic Investment to Solve Cultivated Food Scalability Challenges

https://pluri-biotech.com/releases/pluri-subsidiary-ever-after-foods-secured-10-million-strategic-investment-to-solve-cultivated-food-scalability-challenges/

Pluri Subsidiary Ever After Foods Secured $10 Million Strategic Investment to Solve Cultivated Food Scalability Challenges

https://pluri-biotech.com/releases/pluri-subsidiary-ever-after-foods-secured-10-million-strategic-investment-to-solve-cultivated-food-scalability-challenges/

Shado, Did you listen to the arguments?
Sleven,

MBIO 1.28 hod at 1.02 MLGO 4.57 +28%

Your telling the true there no doubt about that.that dude has some serious issues.

Amarin made agreements with suppliers of IPE to assure they had an ongoing supply based on the FDA approval and ultimate increasing demand to meet the CVD requirement. That occurs in business as there needs to be a mutually beneficial decision by both parties. Demand side purchasing committment an

Micron added to 'US 1 List' at BofA
BofA analysts are adding Micron Technology to the firm's "US 1 List," which is intended to represent a collection of the firm's best investment ideas that are drawn from the universe of Buy-rated, U.S.-listed stocks covered by BofA Global Research fundament